Who owns Ernexa Therapeutics Inc?
- Ticker: ERNA
- CUSIP Number: 114082308
Tip: Access positions for across all investors
Analyze quarterly positions in Ernexa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Ernexa Therapeutics stock
Who bought or sold Ernexa Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| CI Private Wealth | 438k | $526k | 0% | Dec 2025 |
|
| Vanguard Group | 36k | $43k | 222% | Dec 2025 |
|
| Geode Capital Management | 24k | $28k | 15% | Dec 2025 |
|
| Hrt Financial | 13k | $15k | 100% | Dec 2025 |
|
| Sippican Capital Adivsors | 10k | $12k | 0% | Dec 2025 |
|
| BlackRock | 820.00 | $984.000000 | 0% | Dec 2025 |
|
| Fortitude Family Office | 804.00 | $964.960800 | 100% | Dec 2025 |
|
| UBS Group | 600.00 | $720.000000 | 100% | Dec 2025 |
|
| Assetmark | 133.00 | $159.999000 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 10.00 | $12.000000 | 0% | Dec 2025 |
|
| A. Montag and Associates | 8.00 | $10.000000 | 0% | Dec 2025 |
|
| Activest Wealth Management | 3.00 | $3.999900 | 0% | Dec 2025 |
|
Who sold out of Ernexa Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2025 | 31k | $34k |
| Tower Research Capital | Sep 2025 | 5.2k | $5.7k |
| EverSource Wealth Advisors | Sep 2025 | 116.00 | $126.996800 |